Amgen is committed to fostering trust between industry, healthcare professionals and patients.
Amgen contributes to the quality use of medicines in Australia through the provision of education, sponsorship, and support of healthcare professionals to attend educational and scientific meetings. In line with community expectations, we provide public disclosure of these interactions.
As a member of Medicines Australia, Amgen is open and transparent when providing reportable payment or transfer of value to a healthcare professional. Reportable payments or transfers of value include:
Amgen prepares mandatory reports for publication in accordance with the Medicines Australia Code of Conduct, and Australia’s Privacy legislation. The reports identify healthcare professionals by name where their consent has been provided. Where consent has not been provided the information is reported in aggregate.
Since August 2019, the information reported has been stored in a database, administered by Medicines Australia. This database is designed to be searchable as well as downloaded as a CSV file. The information will be available for three years from the date of publication.
For further information about the details in the report, or to search the database, please visit Disclosure Australia.